The therapeutic readiness of probiotics in major depressive disorder: A systematic review of randomised controlled trials
Published online on December 27, 2025
Abstract
Journal of Psychopharmacology, Ahead of Print.
Background:Major depressive disorder (MDD) is a globally prevalent psychiatric condition associated with significant morbidity and often suboptimal treatment outcomes. Probiotics have emerged as a promising adjunctive therapy targeting the gut–brain axis ...
Background:Major depressive disorder (MDD) is a globally prevalent psychiatric condition associated with significant morbidity and often suboptimal treatment outcomes. Probiotics have emerged as a promising adjunctive therapy targeting the gut–brain axis ...